The system, with the capacity to conduct more than 250,000 clinical chemistry tests per year and more than 25,000 immunoassay tests per year, is in development and under review for potential clearance by the U.S. Food and Drug Administration (FDA), the firm said.

Siemens Healthineers added that the new analyzer is suitable for use as a standalone system in hub-and-spoke settings associated with integrated delivery networks.

The firm also unveiled the Atellica CI Max System consisting of the Atellica CI analytical unit and sample handler at AACC 2022. The system, which is also in development, has an integrated clinical chemistry and immunoassay annual capacity of more than 400,000 tests per year and an immunoassay annual workload of 40,000 tests per year, Siemens Healthineers said.

NGS detects mutation that causes spinal muscular atrophy
Gustavo Barcelos Barra and colleagues at Sabin Medicina Diagnostica in Brasilia, Brazil, are developing a next-generation sequencing (NGS) panel that...

Method shown to rapidly identify children’s UTIs
A team led by Dr. Jingcai Wang of Nationwide Children’s Hospital in Columbus, Ohio, has shown that a faster method for diagnosing urinary tract infections...

Drug test detects possibly toxic cannabis derivative
As the cannabis derivative delta-8-THC grows in popularity, drug tests are needed to detect and differentiate it from delta-9-THC, the primary psychoactive...

Improving kidney stone analysis, treatment with AI
To improve diagnosis and better guide treatment, researchers led by Patrick Day of the Mayo Clinic have developed artificial intelligence (AI)-trained...

Studies uncover findings on antibody responses, immunity
Findings from two studies add to a growing body of knowledge that is essential for guiding public health initiatives and might one day enable clinicians...